Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
7.34
-0.17 (-2.26%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Verastem Market Cap
Verastem has a market cap or net worth of $664.74 million as of September 15, 2026. Its market cap has increased by 11.12% in one year.
Market Cap
664.74M
Enterprise Value
612.71M
1-Year Change
11.12%
Ranking
Category
Stock Price
$7.34
ChartMarket Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $664.74M, an increase of 211.64%. That is a compound annual growth rate of 8.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 664.74M | 28.95% |
| Dec 31, 2025 | 515.50M | 124.03% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
| Jan 27, 2012 | 213.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 710.00M |
| Sagimet Biosciences | 676.29M |
| MiMedx Group | 666.13M |
| Phathom Pharmaceuticals | 664.04M |
| Oculis Holding AG | 651.89M |
| AgomAb Therapeutics NV | 643.18M |
| BlossomHill Therapeutics | 639.23M |
| Altimmune | 636.07M |